Shorter Radiotherapy Regimen May Be Better For Certain Patients With Breast Cancer

Friday, August 7, 2015

The Houston Chronicle (8/7, Ackerman) reports that research published in JAMA Oncology suggests that “women with early stage breast cancer are better off with a shorter, more powerful course of radiation therapy.” Investigators “found that patients who received higher doses of whole breast radiation over four weeks experienced fewer side effects and a better quality of life compared to those who received lower doses over six weeks.”

HealthDay (8/7, Preidt) reports that physicians “should use this higher-dose approach – called hypofractionated whole breast irradiation – as a starting point when discussing treatment options with breast cancer patients...said” the investigators.

MedPage Today (8/7, Bankhead) reports that “the authors of an accompanying editorial said ‘the mounting evidence supporting hypofractionation can no longer be ignored.’” Medscape (8/7, Castellino) also covers the story. 

RT-BOOP Risk May Be Low For Young Breast Cancer Patients

Monday, August 3, 2015
Radiation Therapy News (8/1, Newman) reported that while “radiation-induced bronchiolitis obliterans organizing pneumonia (BOOP) is a possible side effect of radiation therapy in women with breast cancer,” researchers “found that the risk is quite low but is more prevalent in older women.” The findings were published in Radiation Oncology.